PTSD

The Food and Drug Administration (FDA) this week declined to approve the use of MDMA — popularly known as Ecstasy or Molly — for MDMA-assisted therapy for treating PTSD, disappointing many Americans who suffer with intractable mental health conditions and had pinned their hopes on the treatment....

The U.S. Food and Drug Administration (FDA) is on the verge of making a historic decision regarding the approval of Lykos Therapeutics MDMA-assisted therapy as a mainstream medical treatment for post-traumatic stress disorder (PTSD). The decision, expected by August 11, could mark a turning point...

The potential of MDMA-assisted therapy (MDMA-AT) for treating post-traumatic stress disorder (PTSD) has garnered significant attention, including many scientific studies that indicate promising results. However, while the majority of the results suggest safety and efficacy, researchers emphasize...

In another bipartisan effort, U.S. Senators Michael Bennet (D-Colo.), Thom Tillis (R-N.C.), Kyrsten Sinema (I-Ariz.), and Rand Paul (R-Ky.), along with 15 colleagues called on the U.S. Food and Drug Administration (FDA) to base its upcoming decision on MDMA-Assisted Therapy for Post-Traumatic...

Congressional leaders and veterans’ advocates converged at the U.S. Capitol to push for MDMA-assisted therapy as a potential breakthrough in PTSD treatment for military veterans. The event, marked by the solemn hanging of 150,000 military dog tags symbolizing lives lost to suicide since 9/11...

In an engaging episode of Benzinga’s Cannabis Insider podcast, hosts Patricio Liddle and Nicolás Rodríguez welcomed Cody Shandraw, president of Healing Realty Trust, to discuss the role of real estate in the burgeoning sector of psychedelic therapies. Shandraw, who spearheads the strategic...

"Unfortunately, the Committee completely lost sight of the big picture," said retired Lieutenant General of the US Marine Corps, Martin R. Steele. He was commenting on this week's recommendation by a committee of advisors to the U.S. Food and Drug Administration against the approval of MDMA-...

A committee of advisors to the U.S. Food and Drug Administration (FDA) dealt a blow to the burgeoning field of psychedelic medicine by recommending against the approval of MDMA-assisted therapy as a treatment for PTSD. MDMA, also known as ecstasy, has been studied for over a decade as a potential...

"Tremendous Excitement" Around Psychedelic Medicine, Says Top Federal Drug Official There is "tremendous excitement" about the therapeutic potential of psychedelics, says National Institute on Drug Abuse (NIDA) Director Nora Volkow. However, this top federal drug official emphasized that while...

VA Under Secretary for Health Shereef Elnahal shared insights on the “unstoppable narrative” of psychedelic medicine, fueled by compelling veterans’ recovery stories and robust scientific research. Speaking at a Horizons psychedelics conference, Elnahal noted that the Department...

James Irey, a 46-year-old veteran who lives in Bloomsburg, Pennsylvania had to face a difficult decision: endure chronic pain or forfeit his constitutional rights. His journey began while serving in the Army in Kosovo where he sustained serious injuries including broken bones, torn ligaments and...

Courtney Barnes, a partner at Feldman Legal Advisors, advocate for psychedelic policy reform and upcoming guest at the Benzinga Cannabis Capital Conference positioned herself at the front lines of the legal landscape for cannabis and psychedelics, steering the conversation around regulation and...

Three Key Takeaways: FDA Nods to MDMA Therapy Application: The FDA has accepted Lykos Therapeutics’ application for MDMA-assisted therapy for PTSD, marking a significant step in recognizing psychedelic therapies’ medical potential. A Milestone in Psychedelic Research: This development...

Indiana legislators are taking aim at mental health and medical issues with a GOP-sponsored Senate bill that would fund state institutions to explore the potential of psilocybin as an alternative treatment for certain mental health disorders. Senate Bill 139,...

In a groundbreaking move, the U.S. Department of Veterans Affairs (VA) is launching new studies on using psychedelic compounds to treat post-traumatic stress disorder (PTSD) and depression among military veterans. This marks a significant shift for the VA, representing the first such research since...